The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2017

Filed:

Feb. 27, 2013
Applicant:

Roquette Freres, Lestrem, FR;

Inventors:

Stephanie Bureau, Essars, FR;

Laetitia Guerin-Deremaux, Nieppe, FR;

Bernard Pora, Hubei, CN;

Assignee:

Roquette Frères, Lestrem, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A23L 1/30 (2006.01); A23L 1/307 (2006.01); C08B 30/18 (2006.01); C12P 19/04 (2006.01); C12P 19/20 (2006.01); A23L 29/30 (2016.01); A23L 33/10 (2016.01); A23L 33/20 (2016.01);
U.S. Cl.
CPC ...
C08B 30/18 (2013.01); A23L 29/30 (2016.08); A23L 29/35 (2016.08); A23L 33/10 (2016.08); A23L 33/20 (2016.08); C12P 19/04 (2013.01); C12P 19/20 (2013.01); A23V 2002/00 (2013.01);
Abstract

Hyper-branched maltodextrins having a dextrose equivalent (DE) between at least 8 and at most 15 and a molecular weight or Mw between at least 1,700 and at most 3,000 daltons, characterized in that same have: a 1,6 glucoside bond content between at least 30 and at most 45%; a soluble indigestible fiber content, which is determined according to the AOAC No. 2001-03 method, between at least 75 and at most 100%; and a hypoglycemic capacity expressed according to a test A, which:—in vitro, results in an 80 to 90% reduction of the α-amylase hydrolysis of standard maltodextrins, and—in situ, by a 30 to 45% reduction in the intestinal digestive activity of standard maltodextrins.


Find Patent Forward Citations

Loading…